McCutcheon, Robert A. http://orcid.org/0000-0003-1102-2566
Pillinger, Toby
Mizuno, Yuya http://orcid.org/0000-0002-3531-8006
Montgomery, Adam
Pandian, Haridha
Vano, Luke http://orcid.org/0000-0003-1624-490X
Marques, Tiago Reis
Howes, Oliver D.
Funding for this research was provided by:
Wellcome Trust (200102/Z/15/Z, 094849/Z/10/Z)
Article History
Received: 26 March 2019
Revised: 5 June 2019
Accepted: 24 June 2019
First Online: 30 August 2019
Compliance with ethical standards
:
: RM, TP, AM, HP and LV declare no financial conflicts of interest. YM has received manuscript fees or speaker’s honoraria from Sumitomo Dainippon Pharma and Yoshitomi Yakuhin, fellowship grants from Japan Society for the Promotion of Science, Astellas Foundation for Research on Metabolic Disorders, Japanese Society of Clinical Neuropsychopharmacology, and Mochida Memorial Foundation for Medical and Pharmaceutical Research, and consultant fees from Bracket within the past three years. ODH has received investigator-initiated research funding from and/or participated in advisory/speaker meetings organised by Astra-Zeneca, Autifony, BMS, Eli Lilly, Heptares, Jansenn, Lundbeck, Lyden-Delta, Otsuka, Servier, Sunovion, Rand and Roche. Neither ODH or his family have been employed by or have holdings/a financial stake in any biomedical company.